Monday, September 25, 2023
April 22 - 28, 2017; Boston, Massachusetts
AAN
Laser Thermal Therapy Effective for Brain Tumors, Epilepsy
AAN
Ocrelizumab Benefits Early and 'Quite Persistent' in MS
AAN
Long-Lasting Effect of Everolimus in Tuberous Sclerosis
AAN
First Neurologist President of AHA Now President of AAN
AAN
Alzheimer's Risk Allele Linked to Disease Severity in CTE
AAN
Alemtuzumab: Durable Efficacy at 6 Years in MS
AAN
Mercury in Fish Tied to a Higher ALS Risk
AAN
AAN Survey: 'Room for Improvement' in Cognitive Testing
AAN
Brain Alterations Linked to PTSD, FND
AAN
Women at 50% Higher Risk for Sports-Related Concussion
AAN
CHERISH: Nusinersen May Improve Motor Function in SMA
AAN
Racial Disparities Found in Access to Neurologic Services
AAN
Phase 3 Trials Positive for Erenumab in Migraine Prevention
AAN
T Cells Targeting Epstein-Barr Virus -- A New Treatment for MS?
AAN
Even Mildly Insufficient Sleep Linked to Depression
AAN
UTIs Linked to Stroke Risk in Women With Preeclampsia
AAN
Football Players May Escape Motor Problems
AAN
New AAN/AES Guideline on SUDEP
AAN
Adult Antiepileptics for PGTC Seizures Effective in Children
AAN
Sepsis Linked to Long-Term Risk for Seizures
AAN
Cannabidiol Reduces Drop Seizures in Lennox-Gastaut
AAN
TOLEDO: Apomorphine Reduces Parkinson's 'Off' Time
AAN
What's Hot at AAN 2017?
AAN
Children in Home Affect Sleep for Women but Not Men
AAN
Fatigue, Limb Problems Predict Worsening MS
AAN
Patients With Epilepsy Want to Know About Death Risk
Medscape Neurology©
WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
